Electromed (ELMD) Q4 2026 Earnings Call Transcript
Home care revenue surged 15.2% as sales rep productivity hit record levels.
Search fresh public links, source activity, and ready-to-use post angles for Medical Device Earnings.
Fresh curated links around Medical Device Earnings are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Home care revenue surged 15.2% as sales rep productivity hit record levels.
Precision Devices revenue jumped 33% on defense, medical, and industrial demand.
Why FDA Clearance Alone Can’t Guarantee Medical Device Success Anonymous (not verified) Thu, 10/15/2026 - 10:12 pharmagather item url Why FDA Clearance Alo...
Third-Quarter Revenue Expected to Surpass All Trailing Quarters Over the Last Calendar Year, Driven by Software and Collectibles Partnership Sales
Medical market sales surged 289% as customers shifted to commercial manufacturing.
What’s Globus going to do with almost $1 billion in cash?
Elevance Health is boosting its outlook for the year as it beat Wall Street analysts' expectations for both profit and revenue in the third quarter.
Package Name: Medicine Stocks Recommended Positions: Long Forecast Length: 7 Days (10/7/26 - 10/14/26) I Know First Average: 2.16% Read The Full Forecast...
Can Carlsmed grow sales faster than expenses?
Glucotrack Inc., a publicly traded medical-device developer based in Rutherford, announced Sept. 24 the pricing of a “best efforts” public offering. This pertains to 169,388 shares...
The medical device giant deserves a lot more attention.
Package Name: Medicine Stocks Recommended Positions: Long Forecast Length: 7 Days (9/22/26 - 9/29/26) I Know First Average: 1.94% Read The Full Forecast...
Angelalign Technology reported a 42.9% revenue increase to $230.7 million and a 79.6% net profit rise for H1 2026, with the board declaring a $100 million interim dividend amid int...
Axogen reported that sales of its innovative nerve repair products generated $70 million for the June quarter, up a very respectable 13%.
Medacta Group SA reports above-market revenue growth of 9.7% in constant currency with a robust adjusted EBITDA margin of 27.8% in c.c. in H1 2026.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.